HAFG
BIIB icon

Hansen & Associates Financial Group’s Biogen BIIB Stock Holding History

Hansen & Associates Financial Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,226
Closed -$232K – 43
2025
Q4 		$232K Buy
+1,226
New +$200K 0.13% 45

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Hansen & Associates Financial Group's BIIB Position: Q1 2026 in Review

Hansen & Associates Financial Group sold out of Biogen (BIIB) in Q1 2026, closing a stake of 1,226 shares — an estimated $232K sold.

Hansen & Associates Financial Group first reported a position in BIIB in Q4 2025 and held it in 1 quarter. The position peaked at $232K in Q4 2025. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Hansen & Associates Financial Group reported no remaining Biogen position as of Q1 2026 after selling out during the quarter.
  • Hansen & Associates Financial Group sold 1,226 Biogen shares in Q1 2026, an estimated $232K.
  • Hansen & Associates Financial Group first reported a position in Biogen in Q4 2025 and held it in 1 quarter.
  • Hansen & Associates Financial Group's Biogen position peaked at $232K in Q4 2025.
  • 1,009 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Hansen & Associates Financial Group's 13F filing for Q1 2026, filed 11 May 2026.